Article
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.
PLoS computational biology - 1 Jan 2018
Verma Ravi Kumar, Abramyan Ara M, Michino Mayako, Free R Benjamin, Sibley David R, Javitch Jonathan A, Lane J Robert, Shi Lei
Abstract excerpt
The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
